Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Australian regulators approve Atomo’s rapid HIV diagnostic kit
    • News

    Australian regulators approve Atomo’s rapid HIV diagnostic kit

    Medtech company Atomo Diagnostics (ASX: AT1) has been granted regulatory approval in Australia for their patented AtomoRapid HIV (1&2) rapid diagnostic kit which will enable testing for HIV with just one drop of blood. The approval granted by the Therapeutic Goods Association (TAG) enables Atomo to commence distribution of the diagnostic test to medical professionals

    Read More
    Public
  • Catapult cashed up with return of US sports, clears debt as sales boom
    • News

    Catapult cashed up with return of US sports, clears debt as sales boom

    Sports data and technology company Catapult Group (ASX: CAT) has thrived since the resumption of American sports that went on hiatus due to COVID-19, seeing a big rise in sales from teams and leagues utilising Catapult solutions in their return-to-play programs. Having held a cash balance of USD $13.9 million as at 30 June 2020,

    Read More
    Public
  • Record number of bets for ‘Horse to have Good Time’ during TAB outage
    • Satire

    Record number of bets for ‘Horse to have Good Time’ during TAB outage

    Despite Tabcorp (ASX: TAH) enduring a server catastrophe on one of the busiest betting days of the year, Aussies have proven that there is much more to their love of horse racing than gambling as droves of punters wagered for the “horses to have a good time” on Saturday.  With the debacle, which Tabcorp have

    Read More
    Public
  • DomaCom to offer investors $250m in affordable housing for essential workers
    • News

    DomaCom to offer investors $250m in affordable housing for essential workers

    Essential workers will soon have more affordable housing in the coming years with DomaCom (ASX: DCL) partnering with BlueCHP to deliver $250 million in affordable housing properties which will be offered to investors fractional property investment opportunities. The $250m commitment is part of the DomaCom Affordable Property Accelerator which will be used to allow investors

    Read More
    Public
  • Watch: Healthia adds optometry and audiology to allied healthcare network
    • News

    Watch: Healthia adds optometry and audiology to allied healthcare network

    Having announced the acquisition of The Optical Company and its 41 optometry clinics, Healthia (ASX: HLA) Chairman Glen Richards and CEO Wesley Coote caught up with Emerald Financial’s Bronte Moore to discuss the allied healthcare market and Healthia’s rapidly growing network. Click below to watch the update. Investors can keep up to date with Healthia

    Read More
    Public
  • IBM flags Dubber tech to be “Best of Breed” in new partnership
    • News

    IBM flags Dubber tech to be “Best of Breed” in new partnership

    Aussie communications tech company Dubber (ASX: DUB) has been given a global tick of approval with their call recording technology selected for IBM’s Cloud for Telecommunications network.  The selection will see Dubber’s Unified Voice Recording solution be integrated into the IBM Cloud for Telecommunications platform which will enable calls to be recorded, transcribed and collect

    Read More
    Public
  • «
  • ‹
  • 555
  • 556
  • 557
  • 558
  • 559
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.